The role of optic nerve lamina region stem cells in age-related optic nerve disease
视神经板区域干细胞在年龄相关性视神经疾病中的作用
基本信息
- 批准号:10443202
- 负责人:
- 金额:$ 42.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAgeAgingAnteriorAnterior Ischemic Optic NeuropathyApoptosisAstrocytesAxonBiologicalBlindnessBlood VesselsCell Culture TechniquesCell DeathCell SurvivalCellsCellular StressCessation of lifeCouplingDefectDiseaseDisease ResistanceDissectionDistalEyeGanciclovirGlaucomaGrowthGrowth FactorHealthHumanIndividualMediatingMembraneMicroRNAsModelingMolecularMusNatural regenerationNeurosphereNon-Rodent ModelNuclear Pore ComplexOptic DiskOptic NervePatientsPhagocytesPhysiologic Intraocular PressurePredispositionPrevalencePrimary Open Angle GlaucomaProcessPropertyProteinsRattusResistanceRetinaRetinal Ganglion CellsRodentRodent ModelRoleStressSupporting CellTechniquesThinkingThymidine KinaseTransgenic MiceTransgenic ModelVesicleVisionage relatedagedaxonopathybiomarker paneldeep sequencingeffective therapyenhancing factorexosomeextracellular vesiclesimprovedimproved outcomein vivoinjury recoveryinnovationmyelinationnanovesiclenerve stem cellnestin proteinneuroprotectionnonhuman primateoptic nerve disorderpostnatalstem cell biomarkersstem cells
项目摘要
The most common age-associated optic nerve (ON)-related causes of vision loss are non-arteritic
anterior ischemic optic neuropathy (NAION) and primary open-angle glaucoma (POAG). Optic nerve head
(ONH) defects contribute to NAION and POAG susceptibility, but the mechanisms responsible for this are
incompletely understood, contributing to a lack of effective treatments. My lab recently discovered that the optic
nerve-laminar region (ONLR) within the ONH, contains a CNS neural stem cell/neural progenitor cell
(NSC/NPC) niche which is depleted during aging. Increased CNS-NPC activity has been shown to improve
baseline CNS activity in aged mice, and NPC depletion impedes CNS recovery following injury.
NPCs secrete extracellular vesicles (‘exosomes’) that mediate many of the positive effects of CNS-
NPCs. We find that administering human ONLR-NPC-secreted exosomes enhance RGC survival ex vivo and
stimulates RGC-neuritigenesis. Depleting ONLR-NPCs in a mouse transgenic model increases markers of
RGC stress, using an RGC stress-marker panel. I hypothesize that ONLR-NPCs support RGC survival, and
they do this in part by vesicle secretion. I predict their loss increases RGC stress and susceptibility to death
after axonal ischemic stress, and supplementing RGCs with ONLR-NPC-extracellular vesicles will enhance
RGC survival after axonal stress. We will prove this with two rodent species and two specific aims.
Specific aim 1: Demonstrate that mouse ONLR-NPC loss results in RGC stress and increases
RGC death in ON disease. We will couple a mouse transgenic model enabling selective ONLR-NPC
depletion, the rodent model of NAION rNAION model, and stereology (statistically robust cell quantification).
We will utilize molecular and cell biological techniques for identifying RGC cell stress and apoptosis. We will
then: A) Determine whether acute ONLR-NPC depletion results in RGC stress, via stress marker analysis and
B) Whether this depletion enhances RGC death after rNAION-induced RGC ischemic axonal stress. I predict
increased RGC stress, demonstrable by increased RGC-pJun expression and increased RGC loss.
Specific aim 2. Confirm that rat ONLR-NPC ‘exosomes’ protect RGCs in culture and in vivo during
ischemic ON stress. We will isolate rat ONLR-NPC secreted vesicles and confirm their ability to enhance
RGC survival, by: A) Administering rat ONLR-NPC vesicles and their dissociated components to cultured rat
RGCs, we will quantify their ability to enhance RGC survival and neuritigenesis. I predict improved RGC
survival and increased neuritigenesis. B) Using the rNAION model, we will intravitreally inject rat ONLR-NPC
derived exosomes and their components and determine whether these vesicles improve RGC survival and
reduce stress-related markers such as CRF and pJun. I predict reduced stress levels and improved long-term
RGC survival. Our innovative approach will identify the factors that contribute to RGC stress resistance and
generate new, improved approaches to treatment of optic nerve diseases.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN L BERNSTEIN其他文献
STEVEN L BERNSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN L BERNSTEIN', 18)}}的其他基金
The role of optic nerve lamina region stem cells in age-related optic nerve disease
视神经板区域干细胞在年龄相关性视神经疾病中的作用
- 批准号:
10707014 - 财政年份:2022
- 资助金额:
$ 42.73万 - 项目类别:
Preclinical Analysis of Ischemic Optic Nerve Treatment
缺血性视神经治疗的临床前分析
- 批准号:
9367979 - 财政年份:2017
- 资助金额:
$ 42.73万 - 项目类别:
Preclinical analysis of ischemic optic nerve treatment
缺血性视神经治疗的临床前分析
- 批准号:
7908779 - 财政年份:2009
- 资助金额:
$ 42.73万 - 项目类别:
Preclinical analysis of ischemic optic nerve treatment
缺血性视神经治疗的临床前分析
- 批准号:
8531941 - 财政年份:2009
- 资助金额:
$ 42.73万 - 项目类别:
Preclinical analysis of ischemic optic nerve treatment
缺血性视神经治疗的临床前分析
- 批准号:
8138465 - 财政年份:2009
- 资助金额:
$ 42.73万 - 项目类别:
Preclinical analysis of ischemic optic nerve treatment
缺血性视神经治疗的临床前分析
- 批准号:
8328685 - 财政年份:2009
- 资助金额:
$ 42.73万 - 项目类别:
Preclinical analysis of ischemic optic nerve treatment
缺血性视神经治疗的临床前分析
- 批准号:
7636201 - 财政年份:2009
- 资助金额:
$ 42.73万 - 项目类别:
Mechanisms of Optic Nerve Stroke Neuroprotection
视神经中风的神经保护机制
- 批准号:
8901174 - 财政年份:2004
- 资助金额:
$ 42.73万 - 项目类别:
A functional approach to treating optic nerve stroke
治疗视神经中风的功能性方法
- 批准号:
7077651 - 财政年份:2004
- 资助金额:
$ 42.73万 - 项目类别:
Mechanisms of Optic Nerve Stroke Neuroprotection
视神经中风的神经保护机制
- 批准号:
8762089 - 财政年份:2004
- 资助金额:
$ 42.73万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome Cargo
TBI 和认知能力下降对阿尔茨海默病脑源性外泌体货物的影响
- 批准号:
10662883 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Recruitment of Cerebellar Circuits with Balance Training for Cognitive Rehabilitation in a Mouse Model of Mild Traumatic Brain Injury
在轻度创伤性脑损伤小鼠模型中通过平衡训练募集小脑回路进行认知康复
- 批准号:
10753349 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别: